MENU
SLRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ACELYRIN (SLRN) Ownership - Who owns ACELYRIN?
Acelyrin Inc is a late-stage clinical biopharmaceutical company... Show more
Profile
Industry
N/A
Address
4149 Liberty Canyon Road
Phone
+1 805 730-0360
Employees
130
Web
https://www.acelyrin.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
221.56M
P/E Ratio
N/A
Total Cash
447.88M
Projected Growth
N/A
Total Debt
6.27M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SLRN
Capitalization
222M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
448M
Total Cash/Share
4.45
Total Debt
6.27M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
458M
P/B Ratio
0.48
Cash Flow
N/A
Earnings
-2.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
18.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-304.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.24
Shares Held By Institutions
1.42B
Shares Outstanding - Current
101M
Total Liabilities
32.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-29.936
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4149 Liberty Canyon Road
Phone
+1 805 730-0360
Employees
130
Web
https://www.acelyrin.com